Literature DB >> 3954643

Intravitreous fibronectin and platelet-derived growth factor. New model for traction retinal detachment.

J H Yeo, J Sadeghi, P A Campochiaro, W R Green, B M Glaser.   

Abstract

In proliferative vitreoretinopathy and trauma, traction retinal detachments result from cellular migration into the vitreous cavity with contractile membrane formation. Cleary and Ryan have established the efficacy of intravitreous injection of autologous blood in reproducing this pathologic process in the rabbit eye. It has previously been shown that two serum components, fibronectin and platelet-derived growth factor, stimulate cellular migration. We now show that contractile membranes and traction retinal detachments occur in 72% of rabbit eyes within three weeks following intravitreous injection of fibronectin and platelet-derived growth factor. These results provide a straightforward new model to study the development of intravitreous cellular membranes and traction retinal detachments.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954643     DOI: 10.1001/archopht.1986.01050150119041

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  16 in total

1.  Dispersion of retinal pigment epithelial cells from experimental retinal holes.

Authors:  S A Bishara; S M Buzney
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

2.  Origin of simple glial epiretinal membranes in an animal model.

Authors:  J S Lean
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

Review 3.  Minireview: Fibronectin in retinal disease.

Authors:  Charles G Miller; Greg Budoff; Jonathan L Prenner; Jean E Schwarzbauer
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-20

4.  Panretinal photocoagulation aggravates experimental proliferative vitreoretinopathy.

Authors:  P V Algvere; K Hallnäs; E Dafgård; A Höög
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

5.  Transferrin and transferrin receptor expression in intraocular proliferative disease. APAAP-immunolabeling of retinal membranes and ELISA for vitreal transferrin.

Authors:  M Weller; P Wiedemann; H Moter; K Heimann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

6.  Clinical, structural and molecular phototherapy effects of laser irradiation on the trabecular meshwork of human glaucomatous eyes.

Authors:  M A Babizhayev; M W Brodskaya; N G Mamedov
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

7.  Ranibizumab is a potential prophylaxis for proliferative vitreoretinopathy, a nonangiogenic blinding disease.

Authors:  Steven Pennock; David Kim; Shizuo Mukai; Matthew Kuhnle; Dal W Chun; Joanne Matsubara; Jing Cui; Patrick Ma; David Maberley; Arif Samad; Robert J Van Geest; Sarit L Oberstein; Reinier O Schlingemann; Andrius Kazlauskas
Journal:  Am J Pathol       Date:  2013-04-09       Impact factor: 4.307

8.  Experimental traction retinal detachment in the cat.

Authors:  C A Wilson; J A Khawly; D L Hatchell; R Machemer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

9.  Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders.

Authors:  L Cassidy; P Barry; C Shaw; J Duffy; S Kennedy
Journal:  Br J Ophthalmol       Date:  1998-02       Impact factor: 4.638

10.  Time course of growth factor staining in a rabbit model of traumatic tractional retinal detachment.

Authors:  I Westra; S G Robbins; D J Wilson; J E Robertson; L M O'Rourke; C E Hart; J T Rosenbaum
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-09       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.